The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

RPVgp5  -  F protein

Rinderpest virus (strain Kabete O)

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of RPVgp5

  • Based on the crystal structure of the NDV F protein, we then predicted the locations of the Morbillivirus glycans: the glycan at position 36 is located in the F protein head, and those at positions 68 and 75 are located near the neck-stalk interface [1].
  • The H polypeptide has receptor-binding and hemagglutinating activity, whereas the F protein mediates virus penetration of the host cell, formation of syncytia, and hemolysis of erythrocytes [2].
  • When expressed from a recombinant vaccinia virus in primate cells infected by MV, the engineered serpin (alpha 1-PDX) specifically inhibited furin-catalyzed cleavage of the F-protein precursor without affecting synthesis of other MV proteins [3].
  • The uncleaved precursor F0 and the F1 subunit from infected cells and extracellular virus were both labeled, indicating that palmitoylation can take place prior to F0 cleavage and that palmitoylated F protein was incorporated into virus particles [4].
  • Immunization of dogs with measles virus (MV) iscoms, prepared either from affinity-purified MV F protein or from purified whole virus, resulted in partial protection against challenge with CDV [5].
 

High impact information on RPVgp5

  • On the other hand, the long 5' UTR of the F mRNA was found to possess the capacity to decrease the F protein production, inhibiting virus replication and yet greatly reducing cytopathogenicity [6].
  • NDV position 36 is not occupied by a glycan; the only glycan in that F protein head also has a fusion control function and grows from residue 366, located only 6 A from residue 36 [1].
  • To investigate the role of H protein in the differential MV host cell specificity and cell fusion activity, H proteins of wild-type MV (IC-B) and Ed were coexpressed with the F protein in Vero cells [7].
  • In the intracellular neutralization experiments, confocal immunofluorescence microscopy showed prominent colocalization of anti-H IgA and H protein inside virus-infected cells, whereas colocalization of anti-F and F protein and of anti-N and N protein was much less, in agreement with the neutralization results [8].
  • The pseudotype bearing the wild-type KA H protein and Edmonston F protein (VSVDeltaG*-KAHF) infected all lymphoid cell lines in which the wild-type MV strains caused CPE as efficiently as VSVDeltaG*-EdHF, but it did not infect any of the cell lines resistant to infection with the KA strain [9].
 

Chemical compound and disease context of RPVgp5

 

Biological context of RPVgp5

  • These results suggest that the F protein transmembrane domain cysteines 506 and 518 participate in structures involved in cell fusion, possibly mediated by palmitoylation [4].
  • Glycosylation of the proteins appeared to be impaired somewhat, and the precursor to the F protein was not completely cleaved by the proteases present in insect host cells [2].
  • The data indicate that the arginine 112 residue is critical for the correct proteolytic cleavage that is required for the membrane fusion activity of the MV F protein [12].
  • No changes were found in the F protein which could explain attenuation of the vaccine; however, each of the mild field isolates had amino acid changes in important functional areas which may be related to their attenuated phenotype [13].
  • Previous studies from this laboratory showed that oligopeptides with amino acid sequences similar to the sequence of the N-terminal region of the F1 polypeptide of paramyxoviruses inhibited the membrane fusing activity of the F protein, and thereby inhibited virus infectivity at the level of penetration and virus-induced cell fusion and hemolysis [14].
 

Anatomical context of RPVgp5

  • This aberrant cleavage appears to have abolished the ability of the F protein to cause syncytium formation [12].
  • As an alternative to detecting physical associations of these proteins by coimmunoprecipitation, further studies were performed with a mutant HPIV3 F protein (F-KDEL) lacking a transmembrane anchor and cytoplasmic tail and containing a carboxyl-terminal retention signal for the endoplasmic reticulum (ER) [15].
  • Accordingly, no F protein could be detected in the HNT-PI cell line, although both the M and H proteins were produced in amounts comparable to those of Ph26 [16].
  • We concluded that the distribution of hydrophobic regions capable of spanning biological membranes determines the fusogenic nature of the F protein [17].
  • The F protein of both the Edmonston strain and a wild-type MV was found to be cleaved in the trans-Golgi cisternae and/or the trans-Golgi network (TGN) [18].
 

Associations of RPVgp5 with chemical compounds

  • As revealed by our previous studies, proteolytic cleavage of the MV F protein precursor into its F1 and F2 subunits, but not of F/H-mediated cellular fusion, was found to be required, since fusion-inhibitory peptides such as Z-D-Phe-L-Phe-Gly (Z-fFG) did not interfere with the induction of proliferative inhibition [19].
  • [3H]palmitic acid was released from F protein upon hydroxylamine or dithiothreitol treatment, indicating a thioester linkage [4].
  • These results and previous findings that formalin-treated virus does not induce antibodies to F protein provide an explanation for atypical measles [20].
  • Treatment of MV or Ad5MVF-infected cells with tunicamycin, an inhibitor of N-linked glycosylation, abolished processing of the F protein [21].
  • CSP reduced the detection of the MV F protein by certain monoclonal antibodies (MAbs) that appeared to recognize nonlinear epitopes [22].
 

Other interactions of RPVgp5

  • The synthesis of H, N and possibly F protein was seen in both lytic and persistent infections, but the synthesis of M protein was only detected in the lytic infection [23].
  • In acute and subacute lesions without associated inflammation, expression of the M, H and F protein was only slightly diminished compared to the N and P protein [24].
 

Analytical, diagnostic and therapeutic context of RPVgp5

References

  1. N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusion. von Messling, V., Cattaneo, R. J. Virol. (2003) [Pubmed]
  2. Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene. Vialard, J., Lalumière, M., Vernet, T., Briedis, D., Alkhatib, G., Henning, D., Levin, D., Richardson, C. J. Virol. (1990) [Pubmed]
  3. Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus. Watanabe, M., Hirano, A., Stenglein, S., Nelson, J., Thomas, G., Wong, T.C. J. Virol. (1995) [Pubmed]
  4. Measles virus fusion protein is palmitoylated on transmembrane-intracytoplasmic cysteine residues which participate in cell fusion. Caballero, M., Carabaña, J., Ortego, J., Fernández-Muñoz, R., Celma, M.L. J. Virol. (1998) [Pubmed]
  5. Canine distemper virus (CDV) immune-stimulating complexes (Iscoms), but not measles virus iscoms, protect dogs against CDV infection. De Vries, P., Uytdehaag, F.G., Osterhaus, A.D. J. Gen. Virol. (1988) [Pubmed]
  6. Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. Takeda, M., Ohno, S., Seki, F., Nakatsu, Y., Tahara, M., Yanagi, Y. J. Virol. (2005) [Pubmed]
  7. Recombinant wild-type and edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity. Takeuchi, K., Takeda, M., Miyajima, N., Kobune, F., Tanabayashi, K., Tashiro, M. J. Virol. (2002) [Pubmed]
  8. Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model. Yan, H., Lamm, M.E., Björling, E., Huang, Y.T. J. Virol. (2002) [Pubmed]
  9. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins. Tatsuo, H., Okuma, K., Tanaka, K., Ono, N., Minagawa, H., Takade, A., Matsuura, Y., Yanagi, Y. J. Virol. (2000) [Pubmed]
  10. Fusion glycoprotein (F) of rinderpest virus: entire nucleotide sequence of the F mRNA, and several features of the F protein. Tsukiyama, K., Yoshikawa, Y., Yamanouchi, K. Virology (1988) [Pubmed]
  11. Molecular analysis of structural protein genes of the Yamagata-1 strain of defective subacute sclerosing panencephalitis virus. IV. Nucleotide sequence of the fusion gene. Komase, K., Haga, T., Yoshikawa, Y., Sato, T.A., Yamanouchi, K. Virus Genes (1990) [Pubmed]
  12. Characterization of a cleavage mutant of the measles virus fusion protein defective in syncytium formation. Alkhatib, G., Roder, J., Richardson, C., Briedis, D., Weinberg, R., Smith, D., Taylor, J., Paoletti, E., Shen, S.H. J. Virol. (1994) [Pubmed]
  13. Nucleotide sequence comparisons of the fusion protein gene from virulent and attenuated strains of rinderpest virus. Evans, S.A., Baron, M.D., Chamberlain, R.W., Goatley, L., Barrett, T. J. Gen. Virol. (1994) [Pubmed]
  14. Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action. Richardson, C.D., Choppin, P.W. Virology (1983) [Pubmed]
  15. Down-regulation of paramyxovirus hemagglutinin-neuraminidase glycoprotein surface expression by a mutant fusion protein containing a retention signal for the endoplasmic reticulum. Tanaka, Y., Heminway, B.R., Galinski, M.S. J. Virol. (1996) [Pubmed]
  16. Restriction of fusion protein mRNA as a mechanism of measles virus persistence. Hummel, K.B., Vanchiere, J.A., Bellini, W.J. Virology (1994) [Pubmed]
  17. The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses. Richardson, C., Hull, D., Greer, P., Hasel, K., Berkovich, A., Englund, G., Bellini, W., Rima, B., Lazzarini, R. Virology (1986) [Pubmed]
  18. The role of subtilisin-like proprotein convertases for cleavage of the measles virus fusion glycoprotein in different cell types. Bolt, G., Pedersen, I.R. Virology (1998) [Pubmed]
  19. Measles virus-induced immunosuppression in vitro is independent of complex glycosylation of viral glycoproteins and of hemifusion. Weidmann, A., Fischer, C., Ohgimoto, S., Rüth, C., ter Meulen, V., Schneider-Schaulies, S. J. Virol. (2000) [Pubmed]
  20. The functions and inhibition of the membrane glycoproteins of paramyxoviruses and myxoviruses and the role of the measles virus M protein in subacute sclerosing panencephalitis. Choppin, P.W., Richardson, C.D., Merz, D.C., Hall, W.W., Scheid, A. J. Infect. Dis. (1981) [Pubmed]
  21. Intracellular processing, glycosylation, and cell-surface expression of the measles virus fusion protein (F) encoded by a recombinant adenovirus. Alkhatib, G., Richardson, C., Shen, S.H. Virology (1990) [Pubmed]
  22. Processing of N-linked oligosaccharides on the measles virus glycoproteins: importance for antigenicity and for production of infectious virus particles. Bolt, G., Pedersen, I.R., Blixenkrone-Møller, M. Virus Res. (1999) [Pubmed]
  23. Persistent and lytic infections with SSPE virus: a comparison of the synthesis of virus-specific polypeptides. Stephenson, J.R., Siddell, S.G., Meulen, V.T. J. Gen. Virol. (1981) [Pubmed]
  24. Restricted expression of viral surface proteins in canine distemper encephalitis. Alldinger, S., Baumgärtner, W., Orvell, C. Acta Neuropathol. (1993) [Pubmed]
  25. Recombinant measles virus requiring an exogenous protease for activation of infectivity. Maisner, A., Mrkic, B., Herrler, G., Moll, M., Billeter, M.A., Cattaneo, R., Klenk, H.D. J. Gen. Virol. (2000) [Pubmed]
  26. Delayed activation of altered fusion glycoprotein in a chronic measles virus variant that causes subacute sclerosing panencephalitis. Watanabe, M., Wang, A., Sheng, J., Gombart, A.F., Ayata, M., Ueda, S., Hirano, A., Wong, T.C. J. Neurovirol. (1995) [Pubmed]
  27. Intracellular processing of measles virus fusion protein. Sato, T.A., Kohama, T., Sugiura, A. Arch. Virol. (1988) [Pubmed]
  28. The hemagglutinin of recent measles virus isolates induces cell fusion in a marmoset cell line, but not in other CD46-positive human and monkey cell lines, when expressed together with the F protein. Tanaka, K., Xie, M., Yanagi, Y. Arch. Virol. (1998) [Pubmed]
 
WikiGenes - Universities